Loading...
Echo IQ Limited
EIQ.AX•ASX
TechnologySoftware - Application
A$0.23
A$0.005(2.27%)
Echo IQ Limited (EIQ.AX) Stock Overview
Explore Echo IQ Limited’s financial performance, market position, analyst ratings, and future outlook.
Revenue Growth
-58.54%
↓ 58.54%
Profit Growth
A$-0.02
↑ 34.56%
EPS Growth
A$-0.02
↑ 40.76%
Operating Margin
-6283.68%
↑ 28.35%
ROE
-105.78%
↑ 34.56%
Dividend Yield
0.00%
Analyst Recommendations data is not available for EIQ.AXAnalyst Recommendations details for EIQ.AX are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.
Company Profile
Echo IQ Limited provides cardiac diagnostics support solution in Australia. The company offers artificial intelligence-assisted diagnostics technology that enhance the diagnosis of structural heart disease, as well as Aortic Stenosis. It primarily serves physicians, health systems, and patients. The company was formerly known as Houston We Have Limited and changed its name to EchoIQ Limited in December 2021. Echo IQ Limited is based in Sydney, Australia.
CEO
Mr. Dustin Haines
Headquarters
309 George Street, Sydney, NSW
Founded
2010